SCHEMBL10169374

SCHEMBL10169374

COC(=O)[C@H]1CCCC[C@@H]1CNC(=O)OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.46
SLC6A2 P23975 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 2/20 0.38
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
GFER P55789 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
DRD2 P14416 2/20 0.36
BTK Q06187 1/20 0.35
ACACB O00763 3/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM3 P20309 1/20 0.35
HTT P42858 1/20 0.34
ACACA Q13085 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10169373 1.00 EPHX1 (0.46) EPHX1SLC6A2KMT2AMEN1ALDH1A1
SCHEMBL22034828 0.97 EPHX1 (0.43) EPHX1SLC6A2KMT2AMEN1ALDH1A1
SCHEMBL228311 0.91 EPHX1 (0.41) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL228310 0.91 EPHX1 (0.41) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL12606791 0.87 EPHX1 (0.47) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL12606792 0.87 EPHX1 (0.47) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL6242877 0.87 EPHX1 (0.47) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL6614441 0.86 EPHX1 (0.54) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL20524870 0.85 EPHX1 (0.46) EPHX1KMT2AMEN1ALDH1A1TSHR
SCHEMBL22815165 0.85 EPHX1 (0.37) EPHX1KMT2AMEN1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10322998-B2 Heterogeneous foldamers containing α, β, and/or γ-amino acids WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-06-18 US disclosed
US-20120021530-A1 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS WISCONSIN ALUMNI RESEARCH FOUNDATION 2012-01-26 US disclosed
US-7858737-B2 Heterogeneous foldamers containing α, β, and/or γ-amino acids WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-12-28 US disclosed
US-7858737-B2 Heterogeneous foldamers containing α, β, and/or γ-amino acids WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10322998-B2 Heterogeneous foldamers containing α, β, and/or γ-amino acids DNPEP, PRKCSH, BCAT1 EPHX1 3891/4885SLC6A2 4820/4885KMT2A 3761/4885
US-20120021530-A1 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS DNPEP, PRKCSH, YWHAZ EPHX1 3782/4885SLC6A2 4810/4885KMT2A 3597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.